Prevail Therapeutics Inc. (PRVL) NASDAQ/NMS (GLOBAL MARKET)

$23 0 (0.00%)

Market Cap: $0

As of 01/21/21 12:00 AM EST. Market closed.

(PRVL)

Prevail Therapeutics Inc. (PRVL) NASDAQ/NMS (GLOBAL MARKET)

$23 0 (0.00%)

Market Cap: $0

As of 01/21/21 12:00 AM EST. Market closed.

COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$22.97
Previous Close
$23
Days Range
$22.97 - $23.13
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
34,246,433
Open
$22.97
Previous Close
$23
Days Range
$22.97 - $23.13
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
34,246,433

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR PREVAIL THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Tyto Acquisition Corp 10% Owner Jan 22, 2021 Buy $22.50 34,284,789 771,407,753 100 Jan 22, 2021, 04:26 PM
Abeliovich Asa President & CEO Dec 30, 2020 Option Exercise $23.02 89,037 2,049,632 2,385,756 Dec 31, 2020, 04:54 PM
Abeliovich Asa President & CEO Dec 30, 2020 Option Exercise $9.84 125,793 1,237,656 2,474,793 Dec 31, 2020, 04:54 PM
Minkow Emily Chief Business Officer Dec 24, 2019 Option Exercise $0.18 13,000 2,340 13,000 Mar 11, 2020, 04:47 PM
Thompson Peter A. Director Jun 24, 2019 Buy $17.00 882,352 14,999,984 13,822,463 Jun 26, 2019, 04:56 PM
GORDON CARL L Director Jun 24, 2019 Buy $17.00 882,352 14,999,984 13,822,463 Jun 26, 2019, 04:55 PM
ORBIMED ADVISORS LLC Director Jun 24, 2019 Buy $17.00 882,352 14,999,984 13,822,463 Jun 26, 2019, 04:54 PM
Buy Sale Option Exercise
Owner Relationship Date Value($)
Tyto Acquisition Corp 10% Owner 01/22/2021 771,407,753
Abeliovich Asa President & CEO 12/30/2020 2,049,632
Abeliovich Asa President & CEO 12/30/2020 1,237,656
Minkow Emily Chief Business Officer 12/24/2019 2,340
Thompson Peter A. Director 06/24/2019 14,999,984
GORDON CARL L Director 06/24/2019 14,999,984
ORBIMED ADVISORS LLC Director 06/24/2019 14,999,984
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2020
06/30/2020
0.27%
1Q
09/30/2020
03/31/2020
0.57%
2Q
09/30/2020
12/31/2019
17.42%
3Q
09/30/2020
09/30/2019
24.14%
4Q
09/30/2020
06/30/2019
39.73%
5Q
Load More

Period of Report: 09/30/2020

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2020
0.27%
1Q
03/31/2020
0.57%
2Q
12/31/2019
17.42%
3Q
09/30/2019
24.14%
4Q
06/30/2019
39.73%
5Q
Load More